Key result
Same-day discharge after epicardial Convergent AF ablation shows 100% feasibility with zero 30-day major complications.
Why the study?
The epicardial surgical stage of convergent hybrid epicardial-endocardial ablation for persistent AF conventionally requires overnight hospital admission, and data on the feasibility of planned same-day discharge following this procedure were limited.
Is planned same-day discharge feasible and safe in patients with persistent atrial fibrillation undergoing the epicardial stage of Convergent hybrid ablation?
Observational (n=20)
Is planned same-day discharge feasible and safe in patients with persistent atrial fibrillation undergoing the epicardial stage of Convergent hybrid ablation?
Planned same-day discharge following the minimally invasive epicardial stage of Convergent hybrid ablation for persistent atrial fibrillation is feasible and safe in selected patients, with no major complications or 30-day readmissions in this initial cohort.
Answers are grounded in this paper and cite their sources.
Supports same-day discharge after epicardial hybrid ablation in selected patients; hypothesis-generating and requires prospective validation before practice change.
Introduction Convergent hybrid epicardial-endocardial ablation (HA) is an effective rhythm-control strategy for patients with persistent atrial fibrillation (AF). The epicardial surgical stage conventionally requires overnight hospital admission, and data on the feasibility of planned same-day discharge following this procedure are limited. Methods We performed a retrospective analysis of patients undergoing the epicardial stage of HA via a minimally invasive posterior pericardioscopic approach under general anaesthesia, with same-day discharge planned. Baseline characteristics, procedural outcomes, and peri-procedural complications were assessed. Primary endpoints were feasibility, defined as successful procedural completion with same-day discharge, and safety, defined as the absence of major complications or unplanned readmissions within 30 days. Results Twenty patients were included (80% male; mean age 66.6 ± 8.4 years; mean BMI 28.2 ± 4.0 kg/m²). AF phenotype included persistent AF (55%), recurrent persistent AF (25%), and long-standing persistent AF (20%), with a mean AF duration of 15.9 ± 15.4 months. The mean left ventricular ejection fraction was 37.0 ± 7.7%, and the mean left atrial volume index was 55.8 ± 10.1 mL/m². All procedures were completed successfully, and all patients achieved planned same-day discharge. There were no major complications or unplanned readmissions at 30-day follow-up. One patient developed a superficial wound infection, which resolved with oral antibiotic therapy. Consusion In this selected cohort, planned same-day discharge following the epicardial stage of Convergent hybrid ablation was feasible and associated with a low complication burden. These findings support further prospective evaluation of day-case pathways for hybrid AF ablation.
No takes yet. Share an insight, caveat, or question.
Ahmed et al. (2026) conducted an observational in Persistent atrial fibrillation (n=20). Planned same-day discharge following the epicardial stage of Convergent hybrid ablation was evaluated on Feasibility (successful procedural completion with same-day discharge) and safety (absence of major complications or unplanned readmissions within 30 days). Planned same-day discharge after the epicardial stage of Convergent hybrid AF ablation achieved 100% feasibility and 0% major complications or unplanned readmissions at 30 days in 20 patients.
Synapse has enriched 10 related papers. Consider them for comparative context: